STOCKS TELEGRAPH

Author: Mahrukh Rehan

  • Bon Natural Life Limited (BON) stock is jumping high to 53.78% – What’s influencing it?

    Bon Natural Life Limited (BON) has seen a push of 53.78% in the aftermarket because the company announced the fiscal year 2021 results. However, the last trading session closed at $3.3 with an increase of 1.66%.

    The fiscal Year 2021 Results – Revealed by BON!

    On 2nd February 2022, BON announced the fiscal year 2021 results. The company reported net revenue of about $25.5 million with a 39.9% increase. Moreover, the gross profit came out to be $7.1 million. Not only this but the general and administrative expenses stated were $1.3 million with a 3.2% decrease. Furthermore, the adjusted EBITDA increased by 46.5% to reach $6.1 million. Last but not the least, net income totaled $4.6 million.

    Now what?

    Bon Natural Life Limited (BON) is thrilled with the business’s strong demand trends and double-digit revenue growth and record revenue. Moreover, these figures are clear evidence about the refined product offering, dedication to development, and status as a key partner to the clients. Due to the prolonged worldwide pandemic, changes in trade relations, and macroeconomic policies, BON has confronted worldwide supply-chain issues.

    Furthermore, the company is optimistic about the group’s ability to manage these circumstances and completely offset challenges over time as they adjust the product mix toward higher-end and better profit commodities in order to boost the pricing power, enhance net profit, enhance quality, and maintain solid cost discipline.

    Initial Purchase Order – What is it?

    BON announced on 12th January 2022 that Chongqing Fudoudou Technology Co., Limited has granted them an initial purchase order for the FeatherPure Women’s Personal Care Gel. The company is very happy to begin working with FDD. This is a once-in-a-lifetime chance for BON to expand its reach into FDD’s enormous retail customer network.

    As women’s health awareness grows, BON expects women’s health expenditure to grow geometrically. And FeatherPure to take the lead in the market. Simultaneously, BON is in talks with FDD about co-developing new healthcare items in response to overwhelming market demand. They anticipate that their relationship with FDD will provide an additional source of revenue growth, with a revenue increase of US$10 million predicted in three years, as well as more attractive value to the shareholders.

  • T-Mobile US, Inc. (TMUS) stock is going up in aftermarket – Here’s why?

    T-Mobile US, Inc. (TMUS) experienced an increase of 7.88% in aftermarket following the announcement that T-Mobile’s Unique Formula makes good Industry-Leading Service Revenue. However, the last trading session closed at $109.58 with an increase of 0.027%.

    Industry-Leading Service Revenue – Fourth Quarter Results

    TMUS announced on 2nd February 2022 that the company’s new formula has made outstanding revenue with amazing cash flow growth. The company experienced service revenues of $15 billion with a net income of about $422 million. Last but not the least, the core adjusted EBITDA totaled $5.7 billion.

    How was TMUS’s quarter?

    The executives have considered this year the best year ever at T-Mobile. TMUS didn’t simply reach the lofty targets in 2021 for user growth, profitability, merger synergies, and network expansion but they smashed them all. The industry-leading year-end achievements such as adding 1.2 million postpaid accounts and 5.5 million postpaid customers. Later it will bring Ultra Capacity 5G to 210 million people demonstrating that the Un-carrier is the fastest-growing wireless provider.

    And TMUS is on track to maintain that position through 2022 and if the company sticks to the winning strategy and makes the investments that have propelled them to this point. Lastly, TMUS is in the finest possible position to keep delivering, with plenty of room to grow.

    $2.5 million donations by TMUS – More about it

    TMUS reported on 1st February that it has announced a donation of about $2.5 million to encourage the next generation of amazing leaders. T-commitment Mobile aims to support organizations and provide opportunities that empower Black scholars, technologists, and business leaders. Moreover, Black History Month is the ideal time to build on and reinforce the Un-commitment carrier’s to Equity in Action. This can be done by working with partners to deliver even more resources to the communities’ young diverse leaders.

    5G Leadership in Auction 110 – Worth it?

    On 31st January 2022, TMUS announced that it spent over $3 billion in FCC Auction 110 to secure more mid-band spectrum for its industry-leading Ultra Capacity 5G network. Moreover, the Un-carrier acquired an average of 21 MHz of mid-band spectrum in critical places across the US. This will be used to add more depth to its already robust Ultra Capacity 5G network. Later it will bring even faster speeds and better performance.

    The company has the largest, quickest, and most dependable 5G network in the world. And they are always working to improve it. Furthermore, TMUS will use this additional spectrum to elevate the 5G network to the next level and deliver even better 5G performance to the clients across the country, while Verizon and AT&T continue to compete for second place in the 5Grace.

  • Entasis Therapeutics Holdings Inc. (ETTX) stock is going high – What’s the reason?

    Entasis Therapeutics Holdings Inc. (ETTX) experienced an increase of 13.10% in premarket following the updates in SEC filing. However, the last trading session closed at $1.45 with a decrease of 1.36%.

    Third Quarter 2021 Financial results by ETTX

    ETTX announced third quarter 2021 financial results on 4th November 2021. The company experienced a net loss of $12.4 million with research and development costs of $9.3 million. Moreover, the general and administrative expenses were $4.3 million with research and development costs around $9.3 million. Last but not the least, cash and cash equivalents came out to be $44.1 million.

    Now what?

    The publication of topline results from the landmark Phase 3 ATTACK study in patients with Acinetobacter infections, where SUL-DUR accomplished all direct and indirect endpoints, was a thrilling era for Entasis. Moreover, SUL-DUR is the first investigational medicine to show efficacy in 28-day all-cause mortality in this patient population, as well as clinical cure rates and safety. Furthermore, the findings suggest that SUL-DUR could be a potentially life-saving treatment for patients with Acinetobacter infections, despite the fact that incremental gains have long been the standard in this field.

    In preparation for the NDA application in mid-2022, ETTX is excited to discuss the data with regulatory agencies. The company also intensified the commercial preparedness activities for SUL-DUR over the last quarter, with the appointment of Anna Diaz Triola as the Chief Commercial Officer to lead the charge. Finally, ETTX is making progress on the rest of the pipeline, with the most recent candidate ETX0462 being published in the prominent magazine Nature. Last but not the least, ETX0462 is the first of a new class of antibiotics that has activity against a wide range of Gram-negative infections, including Pseudomonas aeruginosa and a number of high-priority biothreat diseases.

    Positive Topline Results for Sulbactam-Durlobactam by ETTX

    ETTX announced positive results for Sulbactam-Durlobactam on 19th October 2021. New antibiotics are needed by doctors and patients to combat drug-resistant germs. Moreover, Acinetobacter infections are among the hardest to treat, using a significant amount of healthcare resources while causing pain and suffering to patients. The ATTACK study results are robust and intriguing, revealing great safety and efficacy results as well as favorable and substantial clinical cure rates.

  • IceCure Medical Ltd (ICCM) stock has increased by 11.54% in premarket – What’s driving it high?

    IceCure Medical Ltd (ICCM) experienced an increase of 11.54% in premarket following the updates in SEC filing. However, the last trading session closed at $2.59 with an increase of 10.68%.

    Unaudited 2021 Year-End Financial Results – Newest Updates by ICCM

    ICCM announced unaudited 2021 Year-End Financial Results on 31st January 2022. The company reported that revenues increased from $3.9 million to $4.1 million. Moreover, the cash and cash equivalents came out to be $25.6 million. Beginning with a $15 million private placement early in the year 2021 was a critical year for IceCure. Furthermore, ProSense sales have surged in the United States and Europe. This has been possible because of the expansion of our global distribution network. Furthermore, the ICE3 study in the United States produced encouraging results for the cryoablation technology in the treatment of early-stage breast cancer.

    Now what?

    The company plans to enhance its regulatory and commercial strategy in the US, China, and Japan in 2022. In addition, ICCM intends to work with additional commercial strategic partners. Additional regulatory clearances in key markets, such as the United States and China, will be one of the main priorities.

    Furthermore, ICCM has previously submitted a pre-submission package to the Food and Drug Administration in the United States for early-stage breast cancer with a high risk of surgery. Not only this but ICCM has proposed a De Novo categorization based on the ongoing ICE3 clinical study. Lastly, the team is hopeful that the FDA Breakthrough Device Designation will result in a priority review.

    Notice of Intention – Latest Updates by ICCM

    ICCM announced on 20th December 2021, that European Patent Office is willing to issue a patent for IceCure’s “Cryogen Pump” application. IceCure has created a new cryogenic pump that is submersible in liquid nitrogen and operates in a closed circuit. Furthermore, without the requirement to refill liquid nitrogen, this cryogenic pump can be used for repeated procedures or long-term duration procedures. This pump also allows for temperature control of the cryoprobe, as well as the use of a broader range of cryoprobes and catheters and increases the operating temperature during a procedure.

  • SMART Global Holdings, Inc. (SGH) stock experienced increase of 3.75% – What’s going on?

    SMART Global Holdings, Inc. (SGH) experienced an increase of 3.75% in the premarket. Regarding SGH stock, the company confirmed a two-for-one share split where the shares will begin trading on a post-split basis on 2nd February 2022.

    Partnership of SGH with Meta – More About it

    On 24th January 2022, SGH announced its involvement in delivering AI-optimized architecture and professional services for Meta’s cutting-edge AI supercomputer, the AI Research SuperCluster. Penguin Computing, as among the global leaders in HPC and AI, is working with clients to push the boundaries of Intelligence architecture for ultra-scale environments. For more than 20 years, the company has been customizing HPC and AI solutions so that the customers, like Meta, can rely on the knowledge to help them improve their innovations.

    First Quarter Fiscal 2022 Results by SGH – How was the quarter?

    SGH announced first-quarter fiscal 2022 results on 4th January 2022. The company reported net sales of $470 million with a GAAP gross margin of 26%. Moreover, the non-GAAP gross margin came out to be 27%. The company maintained excellent momentum in the first quarter of fiscal 2022, reaching record sales and non-GAAP gross margins while delivering non-GAAP earnings per share near the top of the target range. Last but not the least, the board of directors approved a two-for-one stock split, which will increase the liquidity and broaden the stakeholder base.

    High-Performance AI Edge Camera Applications – What’s up?

    On 14th December 2021, SGH updated about the new beneficial tool named Qualcomm QCS8250 system-on-chip. With compatibility for Wi-Fi 6 and 5G connectivity, this gadget is optimized for optimum performance while balancing battery economy. The SMART Wireless Inforce 68A1 SoM makes connected intelligent edge technology accessible to a broader community of developers. Last but not the least, this device is meant for reducing the time and risk of incorporating premium tier AI performance into edge camera solutions.

    About SGH

    SMART Wireless Computing is a pioneer in the development of elevated, manufacturing embedded software solutions for the Internet of Things (IoT) applications. Moreover, SGH’s Intelligent Platform Solutions (IPS) division includes SMART Wireless Computing. With developing technologies and creative platforms that create value, boost productivity, and unify periphery, core, and cloud, IPS is speeding up the online transition process.

  • Xilinx, Inc. (XLNX) stock is increasing in aftermarket – What’s happening?

    Xilinx, Inc. (XLNX) experienced an increase of 9.97% in the aftermarket. However, the last trading session closed at $198.32 with an increase of 2.46%.

    Third Quarter 2021 Results by XLNX – How was the quarter?

    XLNX announced third quarter 2021 results on 26th January 2022. The company experienced net revenue of $1,011 million with a GAAP net income of $300 million. Not only this but non-GAAP net income came out to be $325 million. For the first time in the company’s history, Xilinx reached another record quarter, surpassing $1 billion in quarterly sales.

    While XLNX was unable to meet all of the customers’ requests, the results illustrate the team’s unwavering focus and execution in providing the best possible service. Furthermore, with record quarters in both the DCG and A&D end markets, the company experienced wide and solid demand throughout the end markets. A&D’s record performance, along with good ISM and TME results, resulted in a total AIT record and higher overall profitability. Lastly, XLNX’s strength proves that the approach has been implemented successfully.

    What’s Next?

    The sequential increase in A&D, DCG, and TME drove record Q3 sales, resulting in overall sequentially revenue growth of 8% and year-over-year growth of 26%, the fifth quarter in a row of double-digit year-over-year growth. Furthermore, this quarter’s results were driven by record revenues and a favorable business mix, as well as beneficial effects from significant venture investments. Last but not the least, adaptive SoC revenue increased by 5% sequentially and by 30% year over year, accounting for 28% of total revenue.

    Launch of Alveo U55C – What is it?

    XLNX announced the launch of Alveo U55C on 15th November 2021. The new Alveo U55C card is the firm’s most capable Alveo accelerator card ever. It has maximum computing density and HBM storage in the Alveo accelerator range. It works specifically for HPC and big data workloads. Moreover, customers with large-scale compute loads can now build sophisticated FPGA-based HPC grouping using their current data center infrastructure and networking with the new Xilinx RoCE v2-based clustering solution from Xilinx.

  • Clarivate Plc (CLVT) is moving down in aftermarket – Here’s why?

    Clarivate Plc (CLVT) has seen a decrease of 10.63% in aftermarket. However, the last trading session closed at $17.49 with an increase of 6.26%.

    Launch of New Global Research Report – Latest News by CLVT

    CLVT announced on 26th January 2022 that the company’s Institute for Scientific Information has produced new research that provides a new way for analyzing the credit authors of academic works obtained via citations. Getting acknowledgment for your work through citations has an impact on motivation and reputation across the academic field. Moreover, individuals’ employment, promotion, and financing are frequently influenced by their publication of academic research, as are funding and decision-making for academic research institutes and governments.

    In an increasingly global and collaborative environment, where the number of papers with dozens or even hundreds of authors is fast increasing, the need for intelligent, data-driven credit analysis that spans study disciplines and countries is critical. Large author counts, on the other hand, can cause conventional credit analysis tools to become biased.

    Now what?

    As international effort becomes a dominating characteristic of global research, this new measure is a crucial development for the twenty-first century. The company hopes to aid the international research community in delivering more, better research by analyzing the existing and inventive analytical methods. CLVT expects to improve the credit system with an indicator like Collab-CNCI would help accurately recognize research accomplishment and excellence—and thus speed up the pace of advancement.

    Patent Trend Report by CLVT

    CLVT announced on 18th January 2022 that it has issued new research highlighting worldwide insights into how companies use patents and intellectual data, problems and possibilities, and the importance of patents in the creative lifecycle. According to the Clarivate Patent Trend Report 2022, the majority of the firms see patents as a business driver, with the majority (75 percent) claiming that the key goal of their patent strategy is to promote more innovation. The majority of patent portfolios (69 percent) have grown in the last 12 months, owing to budget increases, improved C-suite buy-in, and shifts in business focus, according to the findings.

    So what?

    The findings of this analysis show that patent protection and its role in the innovation lifecycle are still very important to firms all over the world. Despite the ups and downs of the pandemic, enterprises appreciate the benefits and opportunities that patent data can provide. Furthermore, Clarivate is happy to be an experienced patent intelligence and lifecycle partner that can give the insights needed to inform an intellectual strategy which could be critical to successfully navigating ongoing uncertainties and increasing innovation in companies and countries.

  • Exela Technologies, Inc. (XELA) stock is experiencing a decrease of 6.38% – Learn more!

    Exela Technologies, Inc. (XELA) experienced a decrease of 6.38% in the aftermarket following the announcement of report publishing by the Wall Street Reporter. However, the last trading session closed at $0.8599 with an increase of 26.83%.

    Wall Street Reporter – What does the report say?

    XELA reported on 1st February 2022 that Wall Street Reporter has published reports regarding the views of the company’s CEO. Developing megatrends and technology are generating trillion-dollar potential for radical technologies in the way people live, work, and play. The latest insights from industry thought leaders affecting society today and in the decade’s future are highlighted by the Wall Street Reporter.

    XELA CEO’s View Point – Report Revealed!

    According to the CEO, Exela is a global leader in BPM technology. At $207 billion and increasing, the total market potential is enormous. Furthermore, in the SMB sector, there are further growth prospects in digital asset groups or DAGs. Moreover, XELA has a strong competitive influence in the market, which is backed up by significant technological investments and several patents. Furthermore, to increase cloud utilization, XELA has developed a strategy. Many of the platforms, such as intelligent data processing and work-from-anywhere initiatives, are propelling rapid cloud adoption.

    By the end of 2022, the executives expect that all customers and workers will have used the cloud. This is an increase from the previous quarter’s 30%. Aside from COVID-19-related revenue concerns, XELA is witnessing excellent momentum across the board. Not only this but in today’s environment, Exela occupies a strong position. A strengthened balance sheet, which includes equity offerings, debt repurchase, and debt refinancing, improved the liquidity position. Exela will take advantage of the rising global TAM, and this has only been possible because of its better financial position and ongoing operational improvements. Last but not the least, he thinks that XELA has the technology, a long history, and a strong staff base to back up the goal for 2022.

  • Helbiz, Inc. (HLBZ) stock is jumping to 15.03% in aftermarket – What’s driving it high?

    Helbiz, Inc. (HLBZ) experienced an increase of 15.03% in the aftermarket because the company announced in an SEC filing that Palella Salvatore bought 3,00,000 and 200,000 shares for $5.78 and $8.20 per share respectively. However, the last trading session closed at $3.06 with a decrease of 6.71%.

    Partnership Expansion of HLBZ with Segway – Worth it?

    On 21st January 2022, HLBZ announced that it has expanded its partnership with Segway which is a well-known company for transportation services. With the help of this partnership, Segway will deliver a wide range of vehicles to Helbiz, ranging from electric scooters to electric cycles. During the first half of 2022, Helbiz will attain the extraordinary milestone of having over 35,000 owned automobiles on the road around the world.

    Moreover, HLBZ will also test a new Segway T60 Lite scooter prototype. It will have a fish-eye camera and an AI-powered system for detecting and avoiding obstructions. Not only this but it will also help in identifying driveable zones and road boundaries and recognizing pedestrians. Last but not the least, all Segway models are built with cutting-edge Internet of Things (IoT) technology.

    Now what?

    The company is ecstatic to continue working with Segway. The addition of these new automobiles to the fleet is a significant step forward for the company in international markets, demonstrating its commitment to offering safe and technologically advanced sharing services.

    Partnership of HLBZ with Vmoto Soco – What’s up?

    HLBZ announced on 20th January 2022 that it has extended its partnership with Vmoto Soco. It’s an Australian firm that specializes in making electric two-wheeled vehicles. Vmoto Soco could provide Helbiz with a further 2,000 electric mopeds as part of the expanded cooperation. Moreover, the Vmoto vehicle provides Helbiz customers with an additional mode of transportation to and from their selected locations.

    Vmoto Soco has headquarters in China, the Netherlands, and Italy, and operates in 29 countries across Asia, Europe, South Africa, South America, and, more recently, North America. Vmoto Soco and Helbiz will collectively build a more sustainable future by producing and distributing green automobiles. Lastly, Helbiz intends to keep distributing Vmoto devices in European markets in the future.

    What’s Next?

    Helbiz EMEA’s commitment to providing cities with efficient and sustainable mobility is exemplified by its collaboration with Vmoto Soco. Furthermore, the company will be able to expand its presence across Italy with this increased supply of e-mopeds, ensuring that every town has access to safe and efficient sharing services.

  • Marine Petroleum Trust (MARPS) stock is going down in premarket – More About it

    Marine Petroleum Trust (MARPS) stock is going down in premarket – More About it

    Marine Petroleum Trust (MARPS) has seen a decrease of 14.84% in the premarket. However, the last trading session closed at $5.39 with an increase of 4.78%.

    Fourth Quarter Cash Distribution – Latest News

    On 19th November 2021, MARPS announced a $0.106743 per unit quarterly cash dividend to its beneficiary interest unitholders. Marine typically receives royalties two months after the start of oil production and three months after the start of natural gas production. This quarter’s dividend of $0.106743 per unit is greater than last quarter’s $0.064312 per unit. The volume of oil and natural gas generated included within this distribution has increased in comparison to the previous quarter. Last but not the least, this quarter, the realized price for oil produced and included in current distribution climbed, but the realized price for natural gas declined.

    Third Quarter Cash Distribution – What’s up?

    On 20th August 2021, MARPS stated the quarterly cash dividend of $0.064312 per unit to unitholders of equitable interests. This quarter’s dividend of $0.064312 per unit is more than last quarter’s $0.028228 per unit. Moreover, the volume of oil and natural gas produced and included in this distribution has improved in comparison to the previous quarter.

    This quarter, the price of oil and natural gas generated and included in the current distribution increased. This is a greater payout than the $0.044516 per unit paid out in the same quarter of 2020. The price realized for both oil and natural gas has risen compared to the same period in 2020. The volume of oil and natural gas generated and included in the current distribution has reduced when compared to the same period last year.

    About MARPS

    Marine Petroleum Trust is a royalty trust that was established in 1956 under Texas law. Marine was formed with the sole aim of administering and liquidating rights to revenues from certain oil and natural gas licenses in the Gulf of Mexico. This is done in accordance with license agreements and revisions between Marine’s successors and Gulf Oil Corporation. Chevron Corporation, Elf Exploration, Inc, and their affiliated companies now own the Gulf interests.

    The Trust receives 98% of all oil, natural gas, and other mineral royalties collected by Marine Petroleum Corporation, minus the cost of receiving and collecting. Oil accounts for around 60% of Marine’s royalty revenue, while natural gas accounts for about 40%. Marine’s royalty revenues are influenced by a variety of factors, including the wells’ production capacities, seasonal demand swings, and changes in the market price for oil and natural gas.